Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 32% ± 8% | |
GABAergic neuron | 3 studies | 25% ± 4% | |
glutamatergic neuron | 3 studies | 33% ± 9% | |
dendritic cell | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3075.65 | 1445 / 1445 | 100% | 42.46 | 183 / 183 |
ovary | 100% | 2474.09 | 180 / 180 | 100% | 35.28 | 430 / 430 |
lung | 100% | 2509.54 | 578 / 578 | 100% | 35.21 | 1154 / 1155 |
breast | 100% | 2721.84 | 459 / 459 | 100% | 49.24 | 1115 / 1118 |
stomach | 100% | 2429.06 | 359 / 359 | 100% | 38.96 | 285 / 286 |
intestine | 100% | 3057.06 | 966 / 966 | 100% | 34.38 | 525 / 527 |
prostate | 100% | 2826.06 | 245 / 245 | 100% | 41.49 | 500 / 502 |
bladder | 100% | 2883.43 | 21 / 21 | 99% | 29.73 | 501 / 504 |
uterus | 100% | 3059.19 | 170 / 170 | 99% | 29.36 | 456 / 459 |
thymus | 100% | 2597.38 | 653 / 653 | 99% | 28.68 | 600 / 605 |
pancreas | 100% | 1765.38 | 327 / 328 | 99% | 25.53 | 177 / 178 |
brain | 99% | 1368.44 | 2615 / 2642 | 100% | 35.26 | 704 / 705 |
skin | 100% | 2896.84 | 1809 / 1809 | 98% | 34.26 | 461 / 472 |
liver | 100% | 1523.52 | 226 / 226 | 97% | 19.56 | 392 / 406 |
adrenal gland | 100% | 3533.12 | 258 / 258 | 97% | 31.68 | 222 / 230 |
kidney | 100% | 1916.66 | 89 / 89 | 96% | 22.73 | 869 / 901 |
adipose | 100% | 2780.55 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2763.53 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 30.29 | 29 / 29 |
spleen | 100% | 2913.10 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 29.14 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 12.23 | 1 / 1 |
muscle | 100% | 1543.05 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 1609.54 | 845 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 22.91 | 76 / 80 |
peripheral blood | 92% | 2356.47 | 852 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046907 | Biological process | intracellular transport |
GO_0006897 | Biological process | endocytosis |
GO_0006622 | Biological process | protein targeting to lysosome |
GO_0035654 | Biological process | clathrin-coated vesicle cargo loading, AP-3-mediated |
GO_0008089 | Biological process | anterograde axonal transport |
GO_0048490 | Biological process | anterograde synaptic vesicle transport |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_0060155 | Biological process | platelet dense granule organization |
GO_1903232 | Biological process | melanosome assembly |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005769 | Cellular component | early endosome |
GO_0005764 | Cellular component | lysosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0030123 | Cellular component | AP-3 adaptor complex |
GO_0030131 | Cellular component | clathrin adaptor complex |
GO_0030659 | Cellular component | cytoplasmic vesicle membrane |
GO_1904115 | Cellular component | axon cytoplasm |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0031267 | Molecular function | small GTPase binding |
GO_0005515 | Molecular function | protein binding |
Gene name | AP3M1 |
Protein name | AP-3 complex subunit mu-1 (AP-3 adaptor complex mu3A subunit) (Adaptor-related protein complex 3 subunit mu-1) (Mu-adaptin 3A) (Mu3A-adaptin) |
Synonyms | |
Description | FUNCTION: Part of the AP-3 complex, an adaptor-related complex which is not clathrin-associated. The complex is associated with the Golgi region as well as more peripheral structures. It facilitates the budding of vesicles from the Golgi membrane and may be directly involved in trafficking to lysosomes. In concert with the BLOC-1 complex, AP-3 is required to target cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals. |
Accessions | ENST00000355264.9 ENST00000372745.1 Q9Y2T2 |